News

The U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices Advisory Panel this week voted that biventricular (BiV) pacing with Medtronic Inc. devices is beneficial for treating...

cardioverter defibrillator cardiac resynchronization therapy biotronik ilesto DX

The U.S. Food and Drug Administration (FDA) approved Biotronik’s Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices)....

Medtronic Inc. announced clinical trial results showing that heart failure patients treated with its AdaptivCRT feature experienced a nearly 50 percent reduction in atrial fibrillation (...

Biotronik, home monitoring, Biotronik Home Monitoring, BIOTRONIK

Biotronik announced the highly-anticipated results of the Reform study. The study demonstrates that ICD (implantable cardioverter-defibrillator) patients with Biotronik's Home Monitoring...

The U.S. Food and Drug Administration (FDA) announced a final rule for the unique device identification system (UDI) that, once implemented, will provide a consistent way to identify...

A new study of patients who died of sudden cardiac arrest, a usually fatal condition that causes the heart to stop beating, shows the majority who qualified to receive potentially lifesaving...

CardioMEMs

The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee will review two new technologies to help treat heart failure (HF) Oct. 8-9,...

In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and...

Carto 3, Biosense Webster, CartoUnivu

Nationwide data show that although only about 12 percent of X-ray exams are for interventional cardiology or electrophysiology (EP) procedures, nearly 50 percent of a patient’s lifetime radiation...

When a beating heart slips into an irregular, life-threatening rhythm, the treatment is well known: deliver a burst of electric current from a pacemaker or defibrillator. But...

Researchers announced this week that an attempt to expand cardiac resynchronization therapy (CRT) to include more patients with heart failure has failed and an international clinical trial ended...

EP Lab, EP mapping/imaging systems, Ablation systems

St. Jude Medical Inc. today announced U.S. Food and Drug Administration (FDA) approval and first use of MediGuide Enable Ablation Catheters. The ablation catheters, which are used to treat...

The U.S. Food and Drug Administration (FDA) approved Boston Scientific’s IntellaTip MiFi XP catheter and granted 510(k) clearance for the Zurpaz 8.5 French steerable sheath for electrophysiology (...

August 20, 2013 — St. Jude Medical Inc. announced the acquisition of Endosense SA, a Switzerland-based company that has pioneered contact-force measurement in catheter ablation. The acquisition...

Tyrx AIGISRx R Fully Resorbable Antibacterial Envelope Implantation

The first implantation of Tyrx Inc.’s new AigisRx R Fully Resorbable Antibacterial Envelope has taken place at the Vanderbilt Heart and Vascular Institute in Nashville, Tenn., by Christopher R....

Nanostim, leadless pacemaker

There have been several advances in electrophysiology (EP) technologies this past year, many of which were highlighted during the Heart Rhythm Society (HRS) 2013 scientific sessions earlier this...

August 1, 2013 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rhythmia mapping system, a next-generation 3-D mapping and navigation...

The healthcare sector in the United States is facing several reforms, mainly from the implementation of the Patient Protection and Affordable Care Act. However, the results from a survey of 1,710...

July 25, 2013 — The 2013 ESC (European Society of Cardiology) Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy, developed in collaboration with the European Heart Rhythm...